Issue Area - Drug Spending Trends
A Closer Look at Allergies, 2001
Allergies are the sixth leading cause of chronic disease in the U.S., and cost the health care system over $18 billion annually. In this publication, a joint project between the Asthma and Allergy Foundation of America and NPC, we take a closer look factors influencing drug spending for allergies.
A Closer Look at Arthritis, 2002
One in six Americans suffers from arthritis, and the CDC projects that number will grow to one in five by 2020. In this six-page brochure, a collaborative project between the Arthritis Foundation and NPC, we take a closer look at the factors influencing drug spending for treating arthritis.
A Closer Look at Asthma, 2001
Asthma results in approximately 5,000 deaths annually in the U.S. and accounts for nearly half a million hospitalizations, 1.6 million emergency room visits, and over 10 million physician office visits. In this six-page brochure, a joint project between the Asthma and Allergy Foundation of America and NPC, we take a closer look at the factors influencing drug spending for the treatment of asthma.
A Closer Look at Depression, 2002
Clinical depression is a widespread and debilitating illness that cost Americans $44 billion in 1990, making it one of the nation's ten most costly diseases. In this six-page brochure, a collaboration between the National Alliance for the Mentally Ill and NPC, we take a closer look at the factors that influence
drug spending for treating depression.
A Closer Look at Diabetes, 2002
The number of Americans diagnosed with diabetes jumped 49 percent from 1990 to 2000. Diabetes is the main cause of kidney failure, new cases of blindness, and lower limb amputations, and is a major risk factor for heart disease and stroke. In this six-page brochure, a joint project between the American Diabetes Association and NPC, we take a closer look at the factors that influence drug spending for the treatment of diabetes.
A Closer Look at High Blood Pressure, 2001
Roughly 50 million Americans ages six and older have high blood pressure. Left untreated, high blood pressure can lead to heart disease, kidney disease, and stroke. In this six-page brochure, a joint project between the American Heart Association and NPC, we take a closer look at the factors influencing drug spending for the treatment of high blood pressure.
A Closer Look at High Cholesterol, 2001
High cholesterol is a major risk factor in heart disease, the leading cause of death in the U.S., which claims the lives of nearly 460,000 Americans each year. In this six-page brochure, a joint project between the American Heart Association and NPC, we take a closer look at the factors influencing drug spending for the treatment of high cholesterol.
Explaining Drug Spending Trends: Does Perception Match Reality? by Robert Dubois, et al., Health Affairs, Vol. 19, No. 2, March/April 2000
Using large claims databases from managed care and employer-sponsored health benefit plans, this study found increased volume, not rising pricing, accounted for drugs’ higher levels of spending. For more information about the methodology used for this study, see Measuring the Costs and Benefits of Pharmaceutical Expenditures, Expert Review of Pharmacoeconomics and Outcomes Research, October 2002.
Annotated PowerPoint slides related to this article are available.
Measuring the Costs and Benefits of Pharmaceutical Expenditures, by William H. Crown, Davina Ling, and Ernst Berndt, Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 2, No. 5, October 2002
This paper presents a methodological approach for analyzing growth in pharmaceutical expenditures, enabling researchers to disaggregate growth into price and volume components. Research using this methodology (see Explaining Drug Spending Trends: Does Perception Match Reality?) has found increased volume, not price, is the primary driver of pharmaceutical spending growth.
National Health Spending In 2004: Recent Slowdown Led By Prescription Drug Spending, by Cynthia Smith, Cathy Cowan, Stephen Heffler, Aaron Catlin the National Health Accounts Team, Health Affairs, Vol. 25, No. 1,
Jan./Feb. 2006
U.S. health care spending rose 7.9 percent to $1.9 trillion in 2004, or $6,280 per person. Health spending accounted for 16 percent of gross domestic product (GDP), nearly the same as in 2003. The pace of health spending growth has slowed, compared with the 2000–2002 period, for both public and
private payers. Hospital spending accounted for 30 percent of the aggregate increase between 2002 and 2004, and prescription drugs accounted for an 11 percent share—smaller than its share of the increase in recent years and much
slower in absolute terms.
|
